Mizoribine
 OpenBabel02212023462D

 18 19  0  0  1  0  0  0  0  0999 V2000
    1.2564   -1.0052    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9239   -1.4901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6689   -2.2748    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8439   -2.2748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5890   -1.4901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1956   -1.2352    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3590   -2.9422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6946   -3.6959    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4615   -2.8560    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2564   -0.1802    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.5890    0.3047    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.8439    1.0893    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.6689    1.0893    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.9239    0.3047    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1538    1.7568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8183    2.5104    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3590    1.7568    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1956    0.0498    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  5  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4  7  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  7  9  1  0  0  0  0
 10  1  1  1  0  0  0
 10 11  1  0  0  0  0
 10 14  1  0  0  0  0
 11 12  1  0  0  0  0
 11 18  1  6  0  0  0
 12 13  1  0  0  0  0
 12 17  1  6  0  0  0
 13 14  1  0  0  0  0
 13 15  1  1  0  0  0
 15 16  1  0  0  0  0
M  END
>  <CdId>
1885

>  <Mol Weight>
259.216

>  <Formula>
C9H13N3O6

>  <ID>
T1188

>  <Name>
Mizoribine

>  <Synonyms>
Bredinin;NSC 289637

>  <CAS>
50924-49-7

>  <Approved status>
PMDA

>  <Disease>
Immune system

>  <Indication>
Lupus Nephritis; Nephrotic Syndrome; Renal Transplant Rejection; Rheumatoid Arthritis

>  <Pathways>
Proteases/Proteasome

>  <Target>
Tyrosinase inhibitor

>  <Receptor>
monophosphate synthetase

$$$$
